Reversal of obesity-driven aggressiveness of endometrial cancer by metformin

Background: Obesity and diabetes are associated with increased risk and worse outcomes for endometrial cancer. Metformin is a widely prescribed generic drug for the treatment of type II diabetes and metabolic syndrome and may also have anti-tumorigenic effects. Thus, we assessed the metabolic anti-t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Cancer Res
Glavni autori: Guo, Hui, Kong, Weimin, Zhang, Lu, Han, Jianjun, Clark, Leslie H, Yin, Yajie, Fang, Ziwei, Sun, Wenchuan, Wang, Jiandong, Gilliam, Timothy P, Lee, Douglas, Makowski, Liza, Zhou, Chunxiao, Bae-Jump, Victoria L
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834476/
https://ncbi.nlm.nih.gov/pubmed/31720081
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items